BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 16, 2011
View Archived Issues
Novel protein kinase inhibitors reported
Read More
PANORAMA 1 study evaluates panobinostat in multiple myeloma
Read More
Phase III trial assesses olesoxime plus riluzole in ALS
Read More
PARP inhibitor shows promise combined with temozolomide in advanced solid tumors
Read More
GeoVax Labs vaccinates first patient in phase I/II AIDS trial
Read More
Liquidia Technologies and PATH to collaborate
Read More
Catalyst Pharmaceutical moves CPP-115 into clinic
Read More
NKTR-181 trial yields promising results
Read More
BioLineRx to develop novel peptide drugs discovered by Compugen
Read More
Camurus grants Novartis exclusive licensing options
Read More
Threshold reports encouraging results from ongoing TH-302 trial in advanced leukemias
Read More
GSK files for Japanese approval of oral kinase inhibitor in malignant soft tissue sarcoma
Read More
New schistosomiasis vaccine candidate developed in Switzerland
Read More
New malaria vaccines tested in vivo by U.S. investigators
Read More
AVL-292 may alleviate myeloma-related bone disease
Read More
Phase II data encourage further development of aminopeptidase N inhibitor in leukemia
Read More
Salix Pharmaceuticals files NDA for crofelemer
Read More
Metabolic Pharmaceuticals begins investigating AOD-9604 in two new areas
Read More
Onyx Pharmaceuticals joins MMRF's personalized medicine initiative
Read More
New conjugated antisense oligonucleotides prepared in U.S.
Read More
Novel histamine H3 receptor antagonists/inverse agonists disclosed
Read More
Chinese institute patents novel serotonin modulators
Read More
Kyowa Hakko Kirin presents novel kynurenine production inhibitors
Read More
Wilex discusses development of Redectane with FDA
Read More
Catabasis raises additional funding for CAT-2003 development in hypertriglyceridemia
Read More
Dako's HER2 CISH pharmDx kit approved in U.S.
Read More
